Apogee Therapeutics Ownership | Who Owns Apogee Therapeutics?
Apogee Therapeutics Ownership Summary
Apogee Therapeutics is owned by 7.85% institutional investors, 6.34% insiders, and 85.81% retail investors. Vr adviser is the largest institutional shareholder, holding 14.54% of APGE shares.
APGE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Apogee Therapeutics | 7.85% | 6.34% | 85.81% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vr adviser | 8.49M | 14.54% | $337.44M |
| Fmr | 6.92M | 11.84% | $274.79M |
| Wellington management group llp | 4.72M | 8.08% | $187.67M |
| Rtw investments, lp | 2.71M | 4.64% | $107.75M |
| Blackrock funding, inc. /de | 2.69M | 4.60% | $106.72M |
| Vanguard group | 2.25M | 3.84% | $89.22M |
| Driehaus capital management | 2.16M | 3.69% | $85.76M |
| Fairmount funds management | 2.05M | 3.51% | $81.39M |
| State street | 1.66M | 2.83% | $65.77M |
| Paradigm biocapital advisors lp | 1.52M | 2.60% | $60.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vr adviser | 8.49M | 18.99% | $337.44M |
| Fairmount funds management | 2.05M | 7.32% | $81.39M |
| Great point partners | 304.00K | 4.98% | $12.08M |
| Affinity asset advisors | 1.17M | 4.06% | $46.62M |
| Allostery investments lp | 6.00K | 3.32% | $260.58K |
| First turn management | 402.81K | 2.40% | $16.00M |
| Exome asset management | 94.40K | 2.27% | $3.75M |
| Opaleye management | 363.26K | 2.04% | $14.43M |
| Ikarian capital | 232.05K | 1.94% | $10.08M |
| Paradigm biocapital advisors lp | 1.52M | 1.72% | $60.46M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 4.72M | 0.03% | 917.99K |
| Ubs group | 799.47K | 0.01% | 692.31K |
| Paradigm biocapital advisors lp | 1.52M | 1.72% | 563.13K |
| Sofinnova investments | 565.42K | 1.23% | 489.24K |
| Affinity asset advisors | 1.17M | 4.06% | 481.53K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | - | - | -10.70M |
| Ra capital management | - | - | -1.57M |
| Point72 asset management | - | - | -1.23M |
| Adage capital partners gp | 235.00K | 0.01% | -1.06M |
| Woodline partners lp | 57.32K | 0.01% | -812.89K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vestal point capital, lp | 425.00K | 0.76% | 425.00K | $16.89M |
| Opaleye management | 363.26K | 2.04% | 363.26K | $14.43M |
| Great point partners | 304.00K | 4.98% | 304.00K | $12.08M |
| Ikarian capital | 232.05K | 1.94% | 232.05K | $10.08M |
| Sg americas securities | 134.23K | 0.02% | 134.23K | $5.33M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -1.00 |
| Southstate | -5.00 |
| Parallel advisors | -6.00 |
| Raymond james financial | -8.00 |
| Stephens consulting | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 51 | -73.85% | 4,589,108 | -92.07% | 7 | 0.08% | 23 | -75.53% | 20 | -68.75% |
| Jun 30, 2025 | 194 | 9.60% | 57,823,236 | -17.56% | 98 | 0.68% | 93 | 9.41% | 64 | 8.47% |
| Mar 31, 2025 | 178 | 11.25% | 72,188,053 | 28.01% | 124 | 1.19% | 85 | -10.53% | 59 | 55.26% |
| Dec 31, 2024 | 162 | 10.96% | 57,868,275 | 3.16% | 104 | 1.07% | 97 | 29.33% | 38 | -17.39% |
| Sep 30, 2024 | 146 | 4.29% | 56,094,430 | 3.58% | 98 | 1.08% | 75 | -7.41% | 46 | 12.20% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | $42.88K |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | $706.49K |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | $758.28K |
| Dec 04, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | $817.50K |
| Dec 04, 2025 | Henderson Jane | Chief Financial Officer | Sell | $112.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | 18 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 5 |
| 2025 Q1 | - | 10 |
| 2024 Q4 | 2 | 13 |
APGE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools